PYC pyc therapeutics limited

janssen

  1. 1,553 Posts.
    lightbulb Created with Sketch. 2333
    The Chairman's Report gives us guidance on the progress of the Janssen collaboration;

    "Successful delivery on this project should trigger a significant licence fee payment in early 2014," page 3.

    So what is early 2014? The Director's Report provides a tighter timeline;

    "In February 2014 Phylogica hopes to achieve a major technical milestone for the Janssen collaboration that can potentially trigger a significant licence payment," page 18.

    So it would appear that early 2014 is in fact February 2014. A licencing deal with Janssen would be transformational. Not only would it "create opportunities to further expand the relationship with Janssen" but it would also provide compelling validation for the technology. There is much to play for despite the lean year of deal flow.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.28
Change
-0.040(3.03%)
Mkt cap ! $746.5M
Open High Low Value Volume
$1.32 $1.35 $1.28 $764.7K 579.2K

Buyers (Bids)

No. Vol. Price($)
1 4000 $1.28
 

Sellers (Offers)

Price($) Vol. No.
$1.30 40248 3
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.